. Author manuscript; available in PMC: 2017 Dec 1.

Published in final edited form as: Transplantation. 2016 Dec;100(12):2729–2734. doi: 10.1097/TP.0000000000001059

Table 2.

Recipient characteristics by development of right heart failure (RHF)

	No RHF (n=158)	RHF (n=34)	p-value
Age (IQR) (years)	7.6 (1.5–13.9)	10.6 (3.2–13.6)	0.24
BSA (IQR) (m^2)	0.84 (.43–1.4)	1.1 (.6–1.4)	0.25
Gender (% female)	76 (48.1%)	14 (41.2%)	0.57
Cardiac diagnosis, on admission	-	-	0.07
Cardiomyopathy	100 (63.3%)	14 (41.2%)
Congenital	44 (27.9%)	13 (38.2%)
Retransplant	9 (5.7%)	4 (11.8%)
Ventilator support, pre-operative	22 (13.9%)	3 (8.8%)	0.58
High-dose or multiple inotropes	101 (63.9%)	26 (76.5%)	0.23
VAD, pre-operative	21 (13.3%)	3 (8.8%)	0.58
ECMO, pre-operative	9 (5.7%)	3 (8.8%)	0.45
PVRi, pre-operative (IQR) (WU × m²)	2.7 (1.8–4.3)	4.4 (1.8–8.6)	0.01
Graft cold ischemic time (mins)	204.8 ± 64.2	197.7 ± 54.8	0.55
Cardiopulmonary bypass time (mins)	153.7 ± 59.4	163.2 ± 45.6	0.40